Palivizumab 50mg powder and solvent for solution for injection vials
in short Palivizumab 50mg inj vials
previously Palivizumab 50mg injection vials and diluent
- SNOMED code
36024011000001100
previously324886007- Code valid from
- Named
- Active compound
- Palivizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Palivizumab
— 50 mg
based on ingredient substance
- Form & Route
- solutioninjection.intramuscular
Powder and solvent for solution for injection, Intramuscular - Controlled drug
- No Controlled Drug Status
Products
Synagis 50mg powder and solvent for solution for injection vials (AbbVie Ltd)
in short Synagis 50mg inj vials
previously Synagis 50mg powder and solvent for solution for injection vial
Synagis 50mg powder and solvent for solution for injection vials
- SNOMED code
4832511000001106- Named
- Supplier
- AbbVie Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed route
- Intramuscular
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Synagis 50mg powder and solvent for solution for injection vials (AbbVie Ltd) 1 vial4832611000001105 ref. pack |
Discontinued
Legal category: POM | 5013158764743 | No Price Available previously: £306.34 | • Personally Administered |
| — |
Reference packs
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial
- SNOMED code
4832011000001103- Quantity and unit
- 1 vial
- Packs